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Nanomedicine has had a profound impact on the treatment of many diseases especially cancer. 
However, synthesis of multifunctional nanoscale drug carriers often requires multistep coupling 
and purification reactions, which can pose major scale-up challenges.  Here we leveraged 
bioinspired oxidation-triggered polymerization of catechols to synthesize nanoparticles (NPs) 
from the plant polyphenol quercetin (QCT) loaded with a hydrophobic anti-cancer drug, curcumin, 
and functionalized with poly(ethylene glycol) (PEG) for steric stabilization in one reaction step.  
NPs were formed by base-catalyzed oxidative self-polymerization of QCT in the presence of 
curcumin and thiol-terminated PEG upon mixing in a universal solvent (dimethyl sulfoxide), 
followed by self-assembly with the gradual addition of water.  Dynamic light scattering and X-ray 
photoelectron spectroscopy were used to confirm NP PEGylation.  Drug loading was verified by 
UV-Vis spectroscopy.  Curcumin-loaded NPs were efficiently internalized by CT26 murine colon 
cancer cells as determined by flow cytometry and confocal microscopy.  NPs also demonstrated 
sustained release and potent cytotoxicity in vitro.  Moreover, in vivo imaging of CT26 tumor-
bearing Balb/c mice following tail vein injection of DiR-labeled QCT NPs showed steady tumor 
accumulation of the NPs up to 24 h.  This was further supported by significant tumor uptake of 
curcumin-loaded QCT NPs as measured by flow cytometry analysis of tumor homogenates.  Our 
findings present a greener synthetic route for the fabrication of drug-loaded surface functionalized 
NPs from poorly water-soluble plant polyphenols such as QCT as promising anti-cancer delivery 
systems. 
Keywords: Quercetin; curcumin; bioinspired nanoparticles; cancer targeting; green chemistry 
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Cancer is a leading cause of death worldwide, responsible for 9.6 million deaths in 2018.1  
Nonspecific uptake of small molecule anti-cancer drugs, which often results in severe side effects, 
can potentially be mitigated by nanoscale drug carriers.2-4  Among the various types of nanocarriers 
available, a common denominator is the fact that the nanocarrier surface needs to be modified in 
order to impart functionalities such as prolonged in vivo half-life, reduced immunogenicity, and 
selective cellular targeting.5-6  Surface modification techniques typically involve chemical 
conjugation of the desired ligand to the nanocarrier individual components before formation,7-8 or 
conjugation to preformed nanocarriers using reactive linkers or coupling agents.9-10  These 
techniques may also require exhaustive purification processes, which can be lengthy and 
inefficient and must be tailored for each ligand.  The additional synthetic steps required can also 
lead to increased costs and greater regulatory hurdles. 
Naturally-occurring polyphenols have attracted considerable attention in the past decade 
due to their unique features as biocompatible coating precursors for two- as well as three-
dimensional surfaces.11  Polyphenols such as dopamine, pyrogallol, tannic acid, and green tea 
catechins can undergo spontaneous oxidation and subsequent polymerization in aqueous alkaline 
buffers, forming stable surface coatings onto a wide range of substrates.  This oxidative coupling 
process is inspired by naturally-occurring phenomena such as browning of polyphenol-rich fruits 
and vegetables upon air exposure as well as underwater adhesion of marine organisms such as 
mussels.11-13  For example, Lee et al. used dopamine self-polymerization to form thin, surface-
adherent polydopamine films onto various organic and inorganic materials, such as polymers, 
metals, semiconductors, and ceramics.14-15  Li et al. synthesized polyphenol-coated mesoporous 
silica nanoparticles as a scaffold for immobilization of targeting moieties such as aptamers.16  
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Abouelmagd et al. reported tannic acid (TA) as an optically inert coating precursor for polymeric 
NPs, enabling the surface incorporation of albumin, chitosan, and folate-terminated PEG.17  
Polyphenol-mediated surface functionalization is facilitated by the reactivity of oxidized catechol 
moieties toward nucleophiles such as amine- and thiol-bearing ligands, in addition to noncovalent 
(H-bonding, hydrophobic, π-π stacking) interactions and metal chelation.18  These features have 
inspired the development of standalone NPs as potential drug delivery nanocarriers, with the 
additional advantage of facile surface modification with desired ligands by relying on the reactivity 
of the oxidized catechols without using complex coupling reagents.  Such polyphenol NPs have 
been reported using dopamine19-20 and green tea polyphenols.21-23
We have recently devised a green NP synthesis technique by leveraging oxidation-triggered 
self-polymerization of the abundant plant polyphenol quercetin (QCT) in an aqueous alkaline 
buffer.24  We showed that spontaneous oxidation of QCT at basic pH led to a series of coupling 
reactions and self-assembly, producing colloidal aggregates that could be functionalized with 
surface ligands (amine-terminated poly(ethylene glycol) (PEG)), and a small molecule anti-cancer 
drug (doxorubicin (DOX)).  PEGylation and drug loading were facilitated by the reactivity of 
QCT’s oxidized catechol moieties toward nucleophiles, and the ability to form H-bonding and π-
π stacking interactions with DOX.  Drug-loaded NPs exhibited high loading capacities, prolonged 
release, and potent anti-cancer activity.
Our QCT-based multifunctional NP platform was synthesized at ambient conditions without the 
use of any coupling reagents, and the purification process only involved ultrafiltration.  However, the 
first-generation NPs were synthesized under aqueous conditions, which only allowed the 
incorporation of water-soluble drugs such as DOX.  In addition, NP synthesis, surface 
functionalization, and drug loading were performed in sequential steps over several days, which 
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may be inefficient for future scale-up efforts.  For these reasons, we developed a more simplified 
one-pot procedure that would allow QCT polymerization and simultaneous incorporation of 
surface ligands and poorly water-soluble cargo.  We postulated that oxidative self-polymerization 
of QCT can be induced in an organic solvent such as dimethyl sulfoxide (DMSO) by the presence 
of a strong base, rendering the oxidized catechol moieties of QCT reactive toward a nucleophilic 
ligand such as thiol-terminated PEG.  The synthesized “amphiphile” of PEG-QCT oligomers 
would then form colloidal assemblies upon the addition of water, with PEG chains exposed 
outward to impart steric stability in vitro and in vivo.25-28  We further postulated that by adding a 
hydrophobic drug to the reaction mixture in DMSO, the former would become entrapped in the 
NP core during self-assembly, forming a PEGylated drug-loaded nanocarrier.  Curcumin (CUR) 
was chosen as a model hydrophobic drug molecule for its reported anti-cancer, anti-oxidant, anti-
microbial, anti-inflammatory, and neuroprotective properties.29-36  It is also characterized by a 
polyphenolic structure, which would facilitate loading into QCT NPs, and intrinsic fluorescence 
that would enable NP tracking in vitro and in vivo. 
NPs were characterized by dynamic light scattering (DLS) and scanning electron 
microscopy (SEM) to verify their size and morphology.  Surface PEGylation was confirmed by 
Fourier transform-infrared (FT-IR) spectroscopy, surface charge measurements, and X-ray 
photoelectron spectroscopy (XPS).  CUR loading and release, cellular uptake, and cytotoxicity 
experiments in a colon cancer model supported the viability of the one-pot method to produce 
functional CUR-loaded NPs with potent anti-cancer activity.  Finally, passive targeting of the NPs 
in tumor-bearing mice was investigated by in vivo imaging and flow cytometry, further validating 
the potential of the newly designed NPs as an anti-cancer nanomedicine.
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Quercetin (QCT), curcumin (CUR), aluminum chloride (AlCl3), sodium methoxide (NaOMe), 3-
(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), and hydrochloric acid 
(HCl, 10 M) were obtained from Sigma-Aldrich (St. Louis, MO, USA).  Methoxy poly(ethylene 
glycol)-thiol, MW 5000  (mPEG-SH) was obtained from Laysan Bio (Arab, AL, USA). Dimethyl 
sulfoxide (DMSO), triethylamine (TEA), and Tween 20 were obtained from Tedia (Fairfield, OH, 
USA).  1,1’-dioctadecyl-3,3,3’,3’-tetramethylindotricarbocyanine iodide (DiR) was obtained from 
Invitrogen (Thermo Fisher Scientific, Waltham, MA, USA). Phosphate buffered saline 10X (PBS) 
was obtained from Biowest (Nuaillé, France).  Ultrapure water (~18.2 MΩ.cm) was prepared using 
a Millipore Direct-Q 5UV system (EMD Millipore, Billerica, MA, USA).
Synthesis of CUR-loaded QCT NPs
CUR-loaded QCT NPs (QCT@CUR NPs) were synthesized by base-catalyzed oxidative self-
polymerization of QCT as previously described with some modification.24  In a typical procedure, 
QCT (10 mg, 0.033 mmol; from a 50 mg/mL stock solution in DMSO) was mixed with different 
amounts of CUR (from a 20 mg/mL stock solution in DMSO) in a 20 mL glass vial protected from 
light, and the volume was completed to 1 mL with DMSO.  The solution was vortexed to ensure 
complete dissolution and then placed on a magnetic stirring plate (Velp Arex, Usmate, Italy) at 
500 rpm speed.  TEA (9.2 μL, 0.066 mmol) was immediately added and the solution was stirred 
at room temperature (RT) overnight protected from light.  The next day, ultrapure water (3 mL) 
was added dropwise to the DMSO solution under stirring at 500 rpm to induce NP self-assembly.  
After mixing for 1 h, the NP dispersion was transferred to a dialysis membrane (12 – 14 kD 
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MWCO, Spectrum Laboratories Inc., Rancho Dominguez, CA, USA) and dialyzed against 
deionized water for two days, with repetitive changing of the water, to remove DMSO, unreacted 
species and unentrapped drug.  NPs were later centrifuged (1840 × g, 5 min; Hermle Z230A 
centrifuge, Wehingen, Germany) to remove any precipitates of unentrapped CUR.  Drug-free QCT 
NPs were prepared as described above without the addition of CUR.  PEGylated NPs were 
prepared by adding mPEG-SH (50 mg, 10 mM) to the DMSO solution after adding QCT and CUR 
but before the addition of TEA.  DiR-labeled NPs were prepared by mixing QCT (10 mg), DiR 
(0.1 mg), and mPEG-SH (50 mg) in 1 mL DMSO and then adding TEA (9.2 μL).  NP formation 
and purification was performed as described for CUR-loaded NPs.  The composition of the 
different NP formulations is detailed in Table 1.  NPs were lyophilized as needed using a FreeZone 
4.5 L Benchtop Freeze Dryer (Labconco Corporation, Kansas City, MO, USA).
NP characterization by dynamic light scattering (DLS) 
DLS was employed to measure the particle size and zeta potential of the prepared NPs using a 
Nicomp Nano Z3000 instrument (Particle Sizing Systems, Santa Barbara, CA, USA).  Freshly 
prepared NPs diluted in ultrapure water were used for the analysis.  Each measurement was 
performed in triplicate. 
FT-IR and UV-Vis spectroscopy
FT-IR spectroscopy was performed using an IR Affinity-1 spectrometer (Shimadzu, Kyoto, 
Japan), where lyophilized samples were prepared as KBr discs.  UV-Vis spectroscopy (Shimadzu 
UV-1800 spectrophotometer, Kyoto, Japan) was used to ascertain the presence of free –OH groups 
in QCT and QCT NPs using NaOMe and AlCl3/HCl as previously described.24, 37-38  Briefly, two 
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sets of methanolic solutions of QCT and QCT NPs were prepared at 10 μg/mL and their spectra 
were recorded.  Spectra were then recorded immediately after adding NaOMe (1 M in methanol, 
3 drops) to one of the sample sets, and AlCl3 (50 mg/mL in methanol, 6 drops) to the second set.  
The spectra were also recorded immediately after adding HCl (5 M, 3 drops) to the AlCl3 samples.
Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) imaging 
For SEM, a drop of PEGylated CUR-loaded QCT NPs (QCT@CUR@PEG NPs) suspended in 
ultrapure water was placed on double-sided carbon tape mounted on an aluminum stub and left to 
dry overnight prior to imaging using the SEM mode of a Versa 3D microscope (FEI, Netherlands) 
at 2 kV accelerating voltage and 10 mm working distance.  For TEM, a drop of NPs suspended in 
ultrapure water was placed on Formvar-coated copper grids (300 mesh, Electron Microscopy 
Sciences, Hatfield, PA, USA) for 1 min, and the excess liquid was blotted with filter paper prior 
to imaging using the TEM mode on a Versa 3D microscope at an accelerating voltage of 30 kV 
and 10 mm working distance.
Calculation of drug loading and loading efficiency 
CUR loading was measured by UV-Vis after diluting 100 μL of the NPs dispersed in water with 
900 μL DMSO and recording the absorbance at 430 nm, based on a standard curve of CUR 
absorbance vs. concentration in DMSO at 430 nm.  Each measurement was performed in triplicate.  
Drug loading and loading efficiency were calculated according to Equations (1) and (2) as follows:
Drug loading = Weight of loaded CUR / Weight of QCT NPs (1)
Loading efficiency = (Weight of loaded CUR / Theoretical weight of CUR) × 100% (2)
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XPS was employed to verify successful PEGylation of CUR-loaded and drug-free QCT NPs.  NP 
samples were drop-casted onto pre-cleaned24 gold-coated silicon wafers (Micro to Nano V.O.F., 
Haarlem, Netherlands) and left to dry overnight.  XPS measurements were carried out using a 
Thermo Fisher Scientific K-Alpha spectrometer utilizing a 72 W monochromated Al Kα x-ray 
source (with photon energy of 1,486 eV).  The beam was focused to a spot size of 400 microns 
diameter on the sample surface, defining the analysis area, and three spots were scanned per 
sample.  A dual beam flood gun was used to compensate for sample charging.  Elemental 
composition was obtained from high-resolution spectra of the C 1s, O 1s, and S 2p regions.  The 
C 1s peak was set to 285 eV for charge correction.  Data analysis and peak deconvolution was 
conducted using CasaXPS.
In vitro release of CUR from CUR-loaded NPs
One milliliter of freshly prepared PEGylated CUR-loaded NPs (QCT@CUR@PEG NPs) was 
placed in a dialysis membrane (12 – 14 kD MWCO) and then immersed in 30 mL PBS (pH 7.4) 
containing 0.5% Tween 20 in a 60 mL glass vial.   The vial was incubated at 100 rpm and 37 °C 
in a shaking water bath (GFL 1083, Burgwedel, Germany).  At predetermined time points, 10 mL 
samples were withdrawn from the release medium and replaced with an equal volume of fresh 
medium to maintain sink conditions.  The amount of CUR released was determined by measuring 
fluorescence of the samples at 460/40 nm excitation and 528/20 nm emission using a Biotek 
FLx800 fluorescence microplate reader (Winooski, VT, USA).  Results were expressed as 
cumulative % amount of CUR released vs. time.  The experiment was performed in triplicate.
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CT26 murine colon carcinoma cells (ATCC, Manassas, VA, USA) were used as a model cell line 
in this study.  Cells grown in RPMI 1640 medium (Invitrogen, Carlsbad, CA, USA) supplemented 
with 10% fetal calf serum, 1% L-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin 
(Invitrogen) at 37 °C in 5% CO2, and passaged twice a week.
Cytotoxicity assays
Cells were seeded in 96-well plates at a density of 1 × 104 cells per well (n = 4).  After 24 h, cells 
were treated with free CUR (from a 54 mM stock solution in DMSO) or freshly prepared aqueous 
dispersions of CUR-loaded NPs (QCT@CUR_0.25 and QCT@CUR@PEG NPs; 10 mM) at 
concentrations spanning 1 – 1,000 μM CUR in complete media for 72 h.  Note that the DMSO 
concentration in cells treated with free CUR did not exceed 2%, and that CUR concentration in 
the NPs was normalized by measuring drug loading in freshly prepared NPs as depicted in 
Equation 1.  Cells were also incubated with drug-free QCT NPs and PEGylated QCT NPs 
(QCT@PEG NPs) at 1 – 1,000 μg/mL.  After 72 h incubation, media was removed, cells were 
treated with the MTT reagent (0.5 mg/mL in complete RPMI 1640), and then incubated for an 
additional 3 h.  Then, the media was carefully removed, and the formazan crystals were dissolved 
in 100 μL DMSO.  The absorbance was read at 570 nm using a microplate reader (FLUOstar 
Optima, BMG Labtech, Ortenberg, Germany).  Cell viability was expressed as % cell viability 
relative to cells incubated with complete media only.  IC50 was calculated by fitting the data into 
a dose-response curve using Graphpad Prism 6.0e. 
Cellular uptake studies
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Cellular uptake was evaluated in CT26 cells by confocal laser scanning microscopy (CLSM) and 
flow cytometry.  For confocal microscopy, cells (1 × 105 cells per well) were seeded in 4-well 
chamber slides (Nunc Lab-Tek, Thermo Scientific, Rochester, NY, USA) in complete media for 
24 h.  After, cells were incubated with free CUR or freshly prepared CUR-loaded QCT NPs 
(QCT@CUR_0.25 and QCT@CUR@PEG NPs) at concentrations equivalent to 20 μM CUR in 
complete media for 24 h.  At the end of the incubation period, cells were washed three times with 
PBS and then fixed in 4% paraformaldehyde for 10 min.  The fixed cells were then washed, 
mounted with ProLong™ Diamond antifade mountant containing DAPI (Invitrogen), and 
coverslipped.  Imaging was performed using an LSM 780 microscope (Carl Zeiss GmbH, Gena, 
Germany).  DAPI and CUR were excited using the 405 and 488 nm lines of a diode laser, 
respectively.  Emission was filtered between 441 – 495 nm and 495 – 590 nm for DAPI and CUR, 
respectively.  Images were captured using a Plan-Apochromat 20×/0.8 M27 objective.
For flow cytometry analysis, cells (1 × 105 cells per well) were seeded in 24-well plates 
overnight, and then treated with CUR or CUR-loaded QCT NPs (QCT@CUR_0.25 and 
QCT@CUR@PEG NPs) at concentrations equivalent to 20 μM CUR in complete media for 24 h.  
After 24 h, cells were washed, trypsinized, centrifuged, and resuspended in 250 μL PBS.  Cell-
associated fluorescence of CUR was quantified using the FL2 channel detector on a BD 
FACSCalibur flow cytometer (BD Biosciences, San Jose, CA, USA) from at least 10,000 gated 
cells per sample.  The measurements were performed in triplicate. 
 
 Organ biodistribution studies by in vivo imaging
All animal experiments were performed in compliance with the UK Home Office (1989) Code of 
Practice for the housing and care of Animals used in Scientific Procedures.  Mice (4-6-week-old 
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female Balb/c weighing ~20 g, Envigo, UK) were inoculated subcutaneously with 1 × 106 CT26 
cells suspended in 0.1 mL PBS at the lower right flank.  Mice (n = 3) received tail vein injections 
of DiR-labeled PEGylated QCT NPs (DiR-NP) diluted in PBS pH 7.4 at a DiR dose of 18.75 
μg/kg.  Imaging was performed at 1, 4, and 24 h post-injection using an IVIS Lumina Series III In 
Vivo Imaging System (Caliper Life Sciences, Perkin Elmer, USA).  After 24 h, animals were 
euthanized and major organs (spleen, liver, lung, kidney, intestine, heart, and brain) as well as the 
tumors were excised for ex vivo imaging.  Fluorescence images were obtained using the DiR filter 
as previously described.39  The collected fluorescence emission signals were stored in efficiency 
units.
Tumor uptake of CUR-loaded NPs 
To quantify tumor uptake of CUR-loaded NPs, female Balb/c mice (n = 3) bearing CT26 tumors 
were injected via tail vein with PEGylated CUR-loaded QCT NPs (QCT@CUR@PEG NPs) 
dispersed in 200 μL PBS pH 7.4 at a dose equivalent to 6 mg CUR/kg.  At 30 h post-injection, 
animals were sacrificed and tumors were excised.  Tumors were placed in a 6-well plate containing 
2 mL serum-free RPMI 1640 and cut into small pieces using a scalpel.  Two milliliters of serum-
free medium was added to each well and the chopped pieces were transferred to universal test 
tubes.  Digestion enzymes (collagenase type IV and DNase I; Thermo Fisher Scientific) were 
added to each tube at a final concentration of 2 mg/mL and 150 μg/mL for collagenase type IV 
and DNase I, respectively.  Tumor pieces were then incubated for 45 min at 37 °C in a shaking 
water bath, vortexing every 15 min for 30 sec.  After, 10 mL of 1% FBS in PBS was added to each 
tube, and the digested tissues were filtered using a 70 μm cell strainer in order to obtain uniform 
cell suspensions.  The filtered suspensions were each centrifuged at 500 × g for 5 min at 4 °C, the 
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supernatants were discarded, and the pellets were resuspended in 10 mL PBS.  Samples were 
centrifuged again at 500 × g for 5 min at 4 °C, the supernatants were discarded and cell pellets 
were resuspended in 1X ACK lysing buffer (Thermo Fisher Scientific) for 5 min, followed by 
adding 25 mL PBS to each sample.  Cell suspensions were centrifuged again at 500 × g for 5 min 
at 4 °C, and the pellets were resuspended in 200 μL PBS for flow cytometry analysis as described 
above.  Tumor homogenates of untreated animals were used as control.
Statistical analysis
Statistical analysis was performed in Graphpad Prism 6.0e using one-way analysis of variance 
(ANOVA) followed by Tukey’s multiple comparisons test at a significance level of p < 0.05.
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Synthesis and characterization of CUR-loaded PEGylated QCT NPs
An overview of the one-pot QCT NP synthesis procedure and a proposed mechanism for NP 
formation is presented in Figure 1.  We have previously demonstrated that QCT undergoes 
oxidative coupling in basic aqueous conditions yielding oligomers of ~5 monomers that are further 
stabilized by noncovalent interactions to form spherical colloidal aggregates.24  In this study, TEA 
was used to catalyze QCT polymerization in DMSO by deprotonating the o-dihydroxyl groups on 
ring B, making the ring susceptible to nucleophilic addition reactions and leading to the formation 
of QCT oligomers.  NP formation from QCT oligomers was then induced by solvent exchange in 
a process similar to self-assembly of amphiphilic copolymers.  
As shown in Table 2, QCT alone (QCT NPs) formed NPs around 33 nm in size, similar to 
our previous findings.24  The FT-IR spectrum of QCT (Figure S1) showed several characteristic 
bands corresponding to O-H (3000 – 3600 cm-1), C=O (1600 – 1700 cm-1), and C=C aromatic 
stretching (1500 – 1600 cm-1), as well as and O-H bending (1300 – 1400 cm-1).  QCT NPs exhibited 
similar bands, which indicates that QCT oxidation and polymerization did not lead to the formation 
of new functional groups.  
NaOMe, AlCl3, and AlCl3/HCl were used as UV shift reagents to determine the presence 
of free –OH groups in QCT NPs, specifically the o-dihydroxyl groups on ring B, since the 
oxidative coupling reactions behind QCT NP formation relied on oxidation of these groups into 
quinones (Figure 1B).  As depicted in Figure S2, the characteristic absorption bands of QCT 
appeared at 371 nm (band I) and 256 nm (band II).  After adding NaOMe, band I was shifted to 
422 nm, which indicates a free –OH group at C-3.  The presence of a free –OH group at C-7 was 
confirmed by the appearance of a new peak at 327 nm.  The addition of AlCl3/HCl caused a shift 
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in band I to 428 nm, verifying the presence of –OH groups on C-3 and C-5.  Upon the addition of 
AlCl3, band I was shifted to 457 nm, which was 29 nm greater than the shift observed with 
AlCl3/HCl, supporting the presence of o-dihydroxyl groups on ring B (Figure S2).  As for QCT 
NPs, band II appeared at 257 nm while band I was shifted to 348 nm (Figure S2).  The presence 
of a free –OH group at C-3 was confirmed upon the addition of NaOMe, where band I was shifted 
to 476 nm.  A new peak also appeared at 390 nm, which is attributed to the presence of a free –
OH group at C-7.  After adding AlCl3, band I was shifted to 445 nm, confirming the presence of –
OH groups on C-3 and C-5.  The addition of HCl did not affect this shift, which signifies the 
absence of o-dihydroxyl groups on ring B, most likely since they have been oxidized to quinones, 
becoming unavailable to react with AlCl3 (Figure S2).  This supports the proposed NP synthesis 
mechanism depicted in Figure 1B.
PEGylated NPs were obtained by adding mPEG-SH to the reaction in DMSO by exploiting 
the fact that the oxidized catechols on ring B of QCT are susceptible to nucleophilic addition 
reactions (Figure 1B), facilitating the incorporation of amine- or thiol-terminated ligands.  Upon 
incorporation of mPEG-SH, particle size of PEGylated QCT NPs (QCT@PEG NPs) was increased 
to 166 nm.  This is consistent with previous reports, where surface PEGylation of polyphenol NPs 
led to an increase in the hydrodynamic diameter depending on the conformation of the PEG 
chains.20, 40  Given the notable size increase of QCT@PEG NPs compared to QCT NPs (from 33 
to 166 nm), it is probable that part of the PEG chain became incorporated in the NP core.  The FT-
IR spectrum of QCT@PEG NPs (Figure S1) exhibited C-H and C-O-C stretching bands between 
2700 – 3000 cm-1 and 1000 – 1200 cm-1, respectively, attributed to the presence of PEG.
The ability of the NPs to incorporate CUR with or without surface PEGylation was 
investigated by adding CUR at different molar ratios relative to QCT.  As depicted in Table 2, 
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CUR-loaded QCT NPs prepared at QCT: CUR ratios of 1:1, 1:0.5, and 1:0.1 (QCT@CUR_1, 
QCT@CUR_0.5, and QCT@CUR_0.1, respectively) were in the size range 76 – 97 nm and had 
polydispersity indices (PDI) ranging from 0.22 – 0.38.  Drug loading efficiency was lowest for 
QCT@CUR_1 and QCT@CUR_0.5 NPs (4.7 and 9.9%, respectively).  QCT@CUR_0.25 NPs 
with a QCT: CUR ratio of 1:0.25 exhibited the smallest PDI (0.05), and the highest loading 
efficiency (91.0%), indicating that an optimum loading capacity was reached.  The significant size 
increase observed in QCT@CUR_0.25 NPs (140 nm) was likely attributed to the greater amount 
of CUR incorporated compared to the other formulations.  Having obtained NPs with the narrowest 
size distribution and the highest loading capacity with QCT@CUR_0.25 NPs, a QCT: CUR ratio 
of 1:0.25 was chosen for the synthesis of PEGylated CUR-loaded QCT NPs (QCT@CUR@PEG 
NPs).  The NPs exhibited a spherical morphology (Figure 2), a mean hydrodynamic diameter of 
90 nm, a relatively narrow size distribution with a PDI of 0.12, and a loading efficiency of 51.1% 
(Table 2).  The lower loading efficiency of QCT@CUR@PEG NPs compared to their 
nonPEGylated counterparts is likely attributed to steric hindrance by the PEG chains which 
interfered with CUR loading.  The decrease in drug loading capacity in turn resulted in NPs with 
smaller diameter.  CUR loading did not result in any spectral changes as observed by UV-Vis 
(Figure S3), which signifies that CUR is only physically entrapped within the NPs.
Zeta potential measurements were conducted in order to confirm successful incorporation 
of PEG on the NP surface, as PEG is a neutral polymer whereas QCT carries a partially negative 
surface charge due to the presence of electron-rich aromatic rings.  As observed in Table 2, all NPs 
displayed partially negative zeta potential values ranging from -11.3 to -21.7 mV, as previously 
reported for QCT NPs.24  However, the PEGylated formulations, QCT@PEG and 
QCT@CUR@PEG NPs, displayed significantly lower surface charge values (p < 0.001 and p < 
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0.0001, respectively) compared to their nonPEGylated counterparts, QCT and QCT@CUR_0.25 
NPs (Figure 3A).  These findings strongly indicate partial shielding of the negative surface charge 
of QCT by the PEG corona.
NP PEGylation was further verified by XPS to obtain the surface elemental composition 
of the synthesized NPs.  PEGylated NPs (QCT@PEG and QCT@CUR@PEG NPs) showed a 
significant increase in S 2p signals at a binding energy of ~163 eV, attributed to the presence of 
thiol groups of mPEG-SH (Figure 3C).  Moreover, PEGylated NPs were associated with a 
significantly lower C/O ratio (Figure 3D) and an increase in C-O-C components (Figure S4 and 
Figure S5), consistent with XPS measurements of PEGylated NPs.17, 20, 24  These findings 
combined with surface charge measurements corroborate our hypothesis that the one-pot 
procedure can successfully yield surface-functionalized QCT NPs.
In vitro release of CUR from CUR-loaded NPs
CUR release from QCT@CUR@PEG NPs was investigated in PBS at pH 7.4.  As shown in Figure 
4, drug release was sustained throughout the duration of the study, with 50.9% of CUR released 
within the first 4 h, 95.0% released after 24 h, and 99.1% released after 4 days.  Interestingly, we 
observed slower release with the prototype QCT NPs encapsulating DOX, where only 47.1% of 
DOX was released within 24 h and 70.7% released after 4 days.24  The marked difference in release 
kinetics suggest a weaker interaction between CUR and QCT compared to DOX, which facilitated 
drug release.  
Cytotoxicity of CUR-loaded NPs in CT26 cells
Cytotoxicity assays were conducted in order to verify whether the NP synthesis method 
compromised CUR’s pharmacologic activity.  CT26 cells were treated with increasing 
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concentrations of CUR alone or loaded in QCT NPs (QCT@CUR_0.25 and QCT@CUR@PEG 
NPs) up to 72 h.  Drug-free NPs (QCT NPs and QCT@PEG NPs) exhibited low toxicity up to 1 
mg/mL (Figure S6).  As shown in Figure 5, CUR exhibited dose-dependent cytotoxicity with an 
IC50 of 28.5 μM, which was close to literature values.39  PEGylated CUR-loaded NPs 
(QCT@CUR@PEG NPs) were associated with a similar potency at an IC50 of 34.7 μM.  
Conversely, nonPEGylated NPs (QCT@CUR_0.25 NPs) showed a reduction in potency with an 
IC50 of 128.3 μM.  The difference may be attributed to the greater steric stability of 
QCT@CUR@PEG NPs in the cell culture medium imparted by the surface-exposed PEG chains.  
The nonPEGylated NPs were more prone to aggregation, which likely hindered their cellular 
uptake.  Although the new NP formulation of CUR did not significantly enhance its cytotoxicity, 
the NPs were completely soluble in water unlike free CUR, which needed to be solubilized in 
DMSO for the in vitro experiments.
   
Cellular uptake of CUR-loaded NPs by confocal microscopy and flow cytometry
Intracellular uptake of CUR alone or loaded in QCT NPs (QCT@CUR_0.25 and 
QCT@CUR@PEG NPs) was visualized by confocal microscopy, enabled by the intrinsic 
fluorescence of CUR.  CT26 cells were incubated with 20 μM CUR or an equivalent concentration 
in QCT NPs for 24 h.  As observed in Figure 6A, stronger green fluorescence signals were obtained 
from cells treated with free CUR and QCT@CUR@PEG NPs compared to those treated with 
QCT@CUR_0.25 NPs.  The results were consistent with the cytotoxicity experiments, were 
QCT@CUR_0.25 NPs exhibited the lowest potency compared to QCT@CUR@PEG NPs and the 
free drug, which further confirms reduced cellular uptake of the nonPEGylated NPs due to their 
lower stability in the culture medium.  Cellular internalization was also measured by flow 
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cytometry, by quantifying cell-associated mean fluorescence intensities (MFI) (Figure 6B and 
Figure 6C).  Free CUR and QCT@CUR@PEG NPs showed similar MFI values, which were both 
significantly higher than those associated with QCT@CUR_0.25 NPs, in line with confocal 
microscopy observations.  Taken together, the cytotoxicity and cellular uptake experiments 
provided strong evidence on the successful synthesis of functional NPs that are readily internalized 
by the cells with demonstrated in vitro anti-cancer activity.
In vivo biodistribution and tumor uptake of systemically-administered NPs
Having shown promising bioactivity in vitro, in vivo biodistribution studies were carried out on 
PEGylated NPs in CT26 tumor-bearing mice.  NPs were loaded with DiR to enable whole body 
imaging throughout the study, and ex vivo imaging of excised major organs afterwards.  
Representative dorsal view images of control and NP-treated animals are shown in Figure 7A, 
while images of excised organs and their corresponding fluorescence intensities (expressed as total 
radiant efficiency per g organ) are depicted in Figure 7B and Figure 7C, respectively.  Tumor 
accumulation of DiR-labeled NPs can be clearly observed over the time course of the study, as 
indicated by the steady increase in fluorescence signal intensities at the tumor sites from 1 h up to 
24 h.  Excised tumors showed fluorescence intensities that were significantly higher than the 
background signals, indicating some degree of tumor accumulation (Figure 7C).  We also observed 
NP accumulation in the spleen and lung, which may be attributed to NP uptake by phagocytes and 
macrophages of the reticuloendothelial system.  Since whole body images showed strong 
fluorescence signals around the tumors, while tumor accumulation was lower than expected, tumor 
excision for CUR NP-treated animals was performed at 30 h post-injection, to enable more tumor 
uptake to take place.  Flow cytometry analysis of tumor homogenates after the administration of 
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QCT@CUR@PEG NPs at a CUR dose of 6 mg/kg showed significantly higher MFI compared to 
PBS-treated controls (Figure 8), indicating tumor uptake of the NPs following systemic 
administration.  
Page 20 of 40
ACS Paragon Plus Environment































































Oxidative self-polymerization of polyphenols has attracted great interest over the past decade, and 
has mainly been applied to produce versatile multifunctional coatings on a variety of substrates.11, 
13  It has also inspired the development of untemplated standalone NPs from coating precursors 
such as dopamine, tannic acid, green tea polyphenols, and most recently, QCT.  Polyphenol NPs 
have been synthesized through a variety of approaches, all of which have relied on oxidation-
triggered polymerization of the polyphenol precursor.  This may be achieved in aqueous alkaline 
solutions19-20, 24, 40-42 or using an oxidizing agent such as hydrogen peroxide,43 sodium 
metaperiodate,44 or copper sulfate,21, 23 with or without the aid of a chelating agent such as ferric 
chloride.45  The reactive nature of these NPs was exploited to functionalize them with surface 
ligands, drug molecules, or imaging agents through sequential incubation with the molecule of 
interest, followed by additional purification steps.  We present in this work a straightforward 
greener approach to polyphenol NP synthesis where NP formation, hydrophobic drug loading, and 
surface functionalization can be achieved in one step.  The new procedure was carried out at 
ambient conditions and cut down on reaction time and energy consumption.  
UV-Vis analysis revealed that the catechol groups of the second generation QCT NPs were 
oxidized to quinones, similar to what we observed in the prototype NPs, suggesting that they were 
formed via a similar mechanism, i.e. oxidative self-polymerization (Figure 1B).  TEA triggered 
the deprotonation/oxidation of o-dihydroxyl groups on ring B of QCT, leading to the formation of 
reactive quinones.  This was likely followed by a series of coupling reactions that resulted in the 
formation of QCT oligomers.  Solvent exchange with water via dialysis allowed these oligomers to self-
assemble into larger nanoscale aggregates brought together by non-covalent interactions.  Polyphenol 
polymerization in nonaqueous media has only been reported for dopamine, where various substrates 
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were coated with polydopamine in organic protic solvents (ethanol or methanol) containing piperidine 
to deprotonate the catechol moieties and various ligands for simultaneous functionalization.46  In the 
present work, we demonstrate that polyphenol polymerization can also be achieved in DMSO, an 
aprotic universal solvent, which holds great promise for translating the procedure to water insoluble 
polyphenol NP precursors and cargo. 
When we tested the ability of the NPs to incorporate CUR, an optimum drug loading 
capacity and NP polydispersity were achieved at a QCT: CUR molar ratio of 1:0.25, which 
produced the largest size NPs.  Interestingly, when the same QCT: CUR ratio was used to 
synthesize PEGylated NPs, it resulted in a smaller hydrodynamic diameter and a lower drug 
loading capacity.  These observations may be attributed to steric hindrance imparted by the PEG 
chains, which likely interfered with CUR loading, resulting in smaller size NPs.  
We investigated the viability of the one-pot procedure to produce surface-functionalized 
NPs by FT-IR, DLS, and XPS measurements, all of which verified the presence of surface-
immobilized PEG.  PEGylation was also confirmed indirectly by observing enhanced cellular 
uptake and cytotoxicity of PEGylated CUR-loaded NPs (QCT@CUR@PEG NPs) compared to 
nonPEGylated NPs (QCT@CUR_0.25 NPs), which was likely due to the steric stability enabled 
by the PEG corona in serum-containing media.  
In vitro release of CUR was conducted under physiologically relevant conditions, 
achieving sustained release of the drug over several days.  The release kinetics observed in this 
study were faster than those obtained with the first generation DOX-loaded QCT NPs, where NPs 
were sequentially PEGylated and loaded with the drug.  Relatively fast CUR release suggests that 
it is less strongly bound to the QCT core.  This may in part be attributed to crowding by the PEG 
chain entrapped within the NP, as indicated by the marked increase in PEGylated NP size 
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compared to unmodified QCT NPs and reduced drug loading compared to QCT@CUR_0.25 NPs. 
Our findings also indicate that the PEGylation and drug incorporation method (one-pot versus 
multistep approach) may be exploited to tune drug release kinetics.  
CUR released from the NPs maintained its bioactivity, which was demonstrated by the 
comparable potency between QCT@CUR@PEG NPs and free CUR against CT26 cells.  The NPs 
were efficiently taken up by the cells within 24 h as confirmed by confocal microscopy and flow 
cytometry.  The promising in vitro performance of the NPs led us to investigate their 
biodistribution in vivo.  PEGylated DiR-labeled QCT NPs were injected into CT26 tumor-bearing 
mice, and in vivo imaging up to 24 h revealed their gradual tumor accumulation.  Ex vivo imaging 
of excised tumors showed detectable fluorescence signals, with higher NP accumulation observed 
in the spleen and lung compared to the tumors.  Given that in vivo imaging results showed steady 
accumulation of the NPs at the tumor site, we postulated that the NPs were still in the tumor 
vasculature at 24 h post-injection, and that more time was needed for tumor uptake to take place.  
Thus, when tumor-bearing animals were injected with CUR-loaded NPs up to 30 h, measurable 
amounts of CUR were detected by flow cytometry analysis of excised tumor homogenates.  
Bearing in mind the heterogeneous nature of tumor tissues and the less reliable EPR effect, it is 
evident that the synthesized NPs would greatly benefit from an active targeting mechanism.  The 
versatile nature of QCT NPs is expected to allow the convenient fabrication of active targeted NPs 
to achieve more selective tumor accumulation and minimize off-target uptake.  Taken together, 
these preliminary findings revealed valuable information about the in vivo fate of QCT NPs as a 
promising cancer-targeted delivery platform. 
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In this work, we tested the hypothesis that a functional anti-cancer nanomedicine can be 
synthesized from the abundant plant polyphenol QCT in a green one-pot procedure.  PEGylated 
CUR-loaded NPs were synthesized by base-catalyzed oxidative self-polymerization of QCT in 
DMSO, a universal organic solvent, making the oxidized catechol moieties of QCT reactive toward 
a nucleophilic ligand such as thiol-terminated PEG.  The NPs were formed upon gradual addition 
of water, entrapping CUR in the core.  Characterization of the NPs by various techniques 
confirmed our hypothesis.  Bioassays in a murine colon cancer model revealed the potent 
cytotoxicity and efficient cellular uptake of CUR-loaded NPs.  In vivo biodistribution studies 
demonstrated the NPs’ passive targeting potential and shed important insights into their in vivo 
fate.  The unique features of these NPs make them promising candidates as versatile nanocarriers 
with the ability to incorporate hydrophobic drug molecules and surface ligands in a simple 
procedure with minimal equipment.
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Table 1. Summary of the different NPs synthesized in this study.
NP QCT: CUR (mol/mol) QCT (mg) CUR (mg)
QCT - 10.0 -
QCT@PEGa - 10.0 -
QCT@CUR_1 1:1 10.0 12.2
0.5_CUR@QCT 1:0.5 10.0 6.1
0.25_CUR@QCT 1:0.25 10.0 3.0
0.1_CUR@QCT 1:0.1 10.0 1.2
QCT@CUR@PEGa 1:0.25 10.0 3.0
aPEGylated NPs were prepared by adding mPEG-SH (10 mM) to the reaction mixture.
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Table 2. Characterization of the NPs synthesized in this study.
NP Particle size (nm) PDI






QCT 33 ± 5 0.40 ± 0.01 -16.3 ± 1.1 - -
QCT@PEG 166 ± 35 0.37 ± 0.09 -11.3 ± 1.2 - -
QCT@CUR_1 76 ± 6 0.38 ± 0.03 -17.6 ± 1.6 5.8 ± 2.3 4.7 ± 1.9
0.5_CUR@QCT 69 ± 24 0.46 ± 0.05 -16.7 ± 1.2 6.0 ± 2.7 9.9 ± 4.8
0.25_CUR@QCT 140 ± 2 0.05 ± 0.03 -21.7 ± 0.8 27.7 ± 1.8 91.0 ± 6.0
0.1_CUR@QCT 97 ± 18 0.22 ± 0.02 -16.9 ± 0.8 6.3 ± 1.5 51.2 ± 13.5
QCT@CUR@PEG 90 ± 2 0.13 ± 0.01 -11.6 ± 1.0 15.5 ± 9.8 51.1 ± 6.5
aPolydispersity index 
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Figure 1. (A) One-pot synthesis of PEGylated CUR-loaded QCT NPs; (B) Proposed NP formation 
mechanism by base-catalyzed oxidative polymerization of QCT and subsequent self-assembly into 
NPs. (Reproduced with permission from ref. 24.  Copyright The Royal Society of Chemistry).
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Figure 2. (A) SEM and (B) TEM images of PEGylated CUR-loaded NPs (QCT@CUR@PEG 
NPs) showing their spherical morphology. 
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Figure 3. Confirmation of NP PEGylation by DLS and XPS.  (A) Zeta potential of QCT NPs, 
PEGylated QCT NPs (QCT@PEG NPs), CUR-loaded QCT NPs (QCT@CUR_0.25 NPs) and 
PEGylated CUR-loaded QCT NPs (QCT@CUR@PEG NPs).  A significant reduction in zeta 
potential was observed after PEGylation, which verifies successful surface modification of 
QCT@PEG and QCT@CUR@PEG NPs with mPEG-SH; (B) Representative XPS survey spectra 
of QCT, QCT@PEG, QCT@CUR_0.25, and QCT@CUR@PEG NPs; (C) Sulfur content of the 
NPs measured by XPS.  A significant increase in S 2p signals was observed after PEGylation, 
which further confirms surface modification of QCT@PEG and QCT@CUR@PEG NPs with 
mPEG-SH; (D) A significant reduction in C/O atom % ratio signifies an increase in C-O-C 
components on the surface of QCT@PEG and QCT@CUR@PEG NPs, consistent with 
PEGylation.  ***p < 0.001; ****p < 0.0001.  
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Figure 4. Cumulative release of CUR from PEGylated CUR-loaded QCT NPs 
(QCT@CUR@PEG NPs; n = 3) in PBS pH 7.4 showing sustained release over 4 days.
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Figure 5. Cell viability of CT26 cells after 72 h incubation with 0 – 1000 μM free CUR, CUR-
loaded QCT NPs (QCT@CUR_0.25 NPs), or PEGylated CUR-loaded QCT NPs 
(QCT@CUR@PEG NPs) (n = 4).  Free CUR and QCT@CUR@PEG NPs exhibited comparable 
potency with an IC50 of 28.5 and 34.7 μM, respectively, whereas QCT@CUR_0.25 NPs showed 
lower potency with an IC50 of 128.3 μM. 
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Figure 6. Cellular uptake of CUR and CUR-loaded NPs in CT26 cells.  (A) Confocal microscopy 
images of CT26 cells treated with 20 μM free CUR, nonPEGylated CUR-loaded NPs 
(QCT@CUR_0.25 NPs), or PEGylated CUR-loaded NPs (QCT@CUR@PEG NPs) for 24 h.  
Uptake of QCT@CUR@PEG NPs was comparable to free CUR as indicated by the strong 
intracellular green fluorescence signals, while QCT@CUR_0.25 NPs showed much weaker 
fluorescence signals signifying reduced cellular uptake.  Blue: cell nuclei stained by DAPI; green: 
CUR; scale bar = 20 μm; (B) Representative flow cytometry histograms of CT26 cells treated with 
CUR, QCT@CUR_0.25 NPs, or QCT@CUR@PEG NPs for 24 h (n = 3); (C) Mean fluorescence 
intensities (MFI) of the FL-2 channel showing significantly higher cell-associated fluorescence for 
cells treated with free CUR and QCT@CUR@PEG NPs,  compared to untreated cells and cells 
treated with QCT@CUR_0.25 NPs, consistent with confocal microscopy observations.  ****p < 
0.0001.   
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Figure 7. In vivo and ex vivo organ biodistribution of IV-administered DiR-labeled PEGylated 
QCT NPs (DiR-NP) in CT26 tumor-bearing Balb/c mice (n = 3).  (A) Representative whole body 
in vivo images (dorsal view) of DiR-NP-treated animals compared to PBS-treated control obtained 
at 1, 4, 8, and 24 h post-injection showing a steady increase in tumor accumulation of the NPs; (B) 
Representative ex vivo images of excised organs at 24 h post-injection; (C) Quantified 
fluorescence signals of excised organs expressed as total radiant efficiency/g organ after 
subtracting background fluorescence.  Although in vivo images showed significant accumulation 
of the NPs around the tumor, fluorescence intensities of excised lung and spleen were significantly 
higher than those of the tumors, which suggests that the NPs may still be present in the tumor 
vasculature at 24 h.  ****p < 0.0001.
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Figure 8. Tumor uptake of IV-administered PEGylated CUR-loaded NPs (QCT@CUR@PEG 
NPs) at 6 mg/kg CUR in CT26 tumor-bearing Balb/c mice (n = 3).  Tumors were excised 30 h 
post-injection and tissue homogenates were analyzed by flow cytometry.  (A) Representative flow 
cytometry histograms and (B) corresponding MFI of tumor homogenates from untreated and NP-
treated animals showing significant tumor accumulation of CUR.  ****p < 0.0001.
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